LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Study Shows Cells Maintain Active Gene Expression during Mitosis

By LabMedica International staff writers
Posted on 27 Sep 2017
Print article
Image: A photomicrograph of chromosomes in uncondensed form (left) and condensed form in dividing cell (right) (Photo courtesy of Dr. Kenneth Zaret, University of Pennsylvania).
Image: A photomicrograph of chromosomes in uncondensed form (left) and condensed form in dividing cell (right) (Photo courtesy of Dr. Kenneth Zaret, University of Pennsylvania).
A team of cell biologists has found that contrary to commonly held theory, gene expression continues during the process of cell division (mitosis).

Although the genome is generally thought to be transcriptionally silent during mitosis, technical limitations have up to now prevented sensitive mapping of transcription during mitosis and subsequent mitotic exit. To study this period of the cellular life cycle, investigators at the University of Pennsylvania (Philadelphia, USA) used 5-ethynyluridine to pulse-label transcripts generated by a human liver cell line during mitosis and mitotic exit. Gene activity was followed using advanced analytical techniques such as FITC-UTP (fluorescein isothiocyanate - uridine triphosphate) labeling, RNA FISH (fluorescence in situ hybridization), and RT-qPCR (real-time polymerase chain reaction).

The investigators reported in the September 14, 2017, online edition of the journal Science that many genes exhibited transcription during mitosis, as confirmed by the analytical procedures. The first round of transcription immediately following mitosis primarily activated genes involved in the growth and rebuilding of daughter cells, rather than cell type-specific functions. These results implied that the cell’s transcription pattern was largely retained at a low level through mitosis, whereas the amplitude of transcription observed in interphase was re-established during mitotic exit.

"We looked at this question from the point of view of answering what controls cell identity and how can we harness that for cell reprogramming - for instance, to stop cancerous replication or engineer a cell to steer the direction of its "personality," so to speak," said senior author Dr. Kenneth S. Zaret, professor of cell and developmental biology at the University of Pennsylvania. "The set of genes a cell expresses determines if it is a skin cell, nerve cell, or a heart muscle cell, among the 200 or so different cell types found in the human body."

"The most amazing thing about this study is that in the end, we had to throw what we thought we knew about this basic aspect of gene regulation out the window," said Dr. Zaret. "The findings indicate that we need to think about how promoters, rather than enhancers, are regulated during cell division. This refocusing will tell us how a cell's identity, as defined by the genes it expresses, is retained through cell division. We hope it will improve our ability to deliberately change a cell's identity to create new cells and tissues for therapeutics and research."

Related Links:
University of Pennsylvania

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crytal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more